Clinical Trials Logo

Filter by:
NCT ID: NCT06257498 Completed - Brain Tumor Clinical Trials

Upright Open MRI for Brain Imaging in Children - a Pilot Study

Heads-Up
Start date: January 25, 2022
Phase: N/A
Study type: Interventional

PRIMARY OBJECTIVE To establish feasibility and acceptability of diagnostic brain MRI in young children for specified indications using an upright MRI system without sedation or anaesthesia. SECONDARY OBJECTIVES To establish how young children who undergo brain MRI using upright MRI view the experience To establish how parents / carers of young children who undergo brain MRI using the upright MRI view the experience for their child and for themselves. To establish how image quality compares between brain MRI using the upright MRI scanner and the standard MRI scanner used in clinical practice.

NCT ID: NCT06256172 Completed - Hypertension Clinical Trials

Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension

Medlink
Start date: June 16, 2023
Phase: N/A
Study type: Interventional

MEDLINK IS A POCKET-SIZED MEDLINK is a pocket-sized, verbally interactive, programmable medical device that allows physicians to select which medical measurements they would like to take for a specific patient. The Physiological Parameters that can be measured by MEDLINK include, but is not limited to: Electrocardiography (ECG), Blood Pressure, Heart Rate, Blood Glucose, Pulse Rate, Blood Oxygen Saturation (SPO2), Electromyography (EMG) body temperature, and Respiratory Data. MEDLINK is a pocket-sized, verbally interactive, programmable medical device that allows physicians to select which medical measurements they would like to take for a specific patient. When the patient takes MEDLINK home and switches it on, the device verbally guides the patient to acquire the measurements requested by the his or her physician. This information is transmitted to the physican's email for medical analysis, check up and/or follow up. This Study was executed by TWO (2) MEDICAL CONSULTANTS: Dr. Michael Olawuyi (mgolawuyi@gmail.com) and Dr, Matthew Olawuyi (olawuyiracettnigerialtd@outlook.com)

NCT ID: NCT06256107 Completed - Clinical trials for Motor Neuron Disease

Virtual Reality in Motor Neurone Disease

VR in MND
Start date: January 13, 2021
Phase: N/A
Study type: Interventional

Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication. The purpose of this study is to establish if Virtual Reality is useful for people with MND and if it helps improve their well being.

NCT ID: NCT06256081 Completed - Clinical trials for Hearing Loss, Conductive

Testing a New App for Children With Glue Ear

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

To assess whether children with glue ear ( and some normal hearing controls) and their families find the Hear Glue Ear application acceptable and easy to use. Whether the hearing screening section on the app is comparable to the hearing test data obtained from formal audiology hearing tests.

NCT ID: NCT06251154 Completed - Myopia Clinical Trials

Clinical Comparison of Two Soft Contact Lenses

Start date: December 11, 2023
Phase: N/A
Study type: Interventional

This study was designed to gather short-term clinical performance data for 2 soft contact lenses.

NCT ID: NCT06240663 Completed - Insulin Resistance Clinical Trials

Walking Before or After Breakfast - Which is Better to Improve Health in Overweight Individuals?

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effectiveness of a home-based walking-based exercise intervention undertaken in the fed or fasted state to improve glycaemic control in overweight and obese individuals. This study will evaluate the adherence and compliance to this "real-world" exercise programme that requires no face-to-face contact with the research team. It is also hypothesised that individuals who exercise before breakfast (fasted) will see greater improvements in glycaemic control than those who exercise after breakfast.

NCT ID: NCT06236659 Completed - Nutrition Clinical Trials

Acute Resistance Exercise and Hydrolyzed Collagen Supplementation

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

This study aimed to investigate the effect of different doses of hydrolyzed collagen (HC) with resistance exercise (RE) on whole body collagen synthesis in middle-aged males and females.

NCT ID: NCT06225440 Completed - Clinical trials for Well-Being, Psychological

Impact of Levagen+® Palmitoylethanolamide (PEA) in a Cross-Over Trial Examining Stress and Cognition in University Students

IMPRESS
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The goal of this randomised cross-over trial is to learn about the effects of Levagen+® Palmitoylethanolamide (PEA) supplementation on cognition, wellness and well-being in young and healthy university students. The main question it aims to answer is: • Does the PEA supplementation affect parameters of stress, mood, cognition and well-being in university students? Participants will complete 2 baseline on-site visits during which they will be assigned to Levagen+® Palmitoylethanolamide (PEA) treatment or placebo arm each time and: - complete anthropometric measurements, questionnaires and surveys, - undergo blood and saliva sampling - complete a cognitive assessment (CANTAB) - a randomly chosen cohort will also measure heart rate variability (HRV) over 3 days. Researchers will compare the PEA treatment group to the placebo to see if there is a significant difference.

NCT ID: NCT06212596 Completed - Clinical trials for Relapsed or Refractory Multiple Myeloma

Selinexor, Cyclophosphamide and Prednisone in Myeloma

MUKtwelve
Start date: July 16, 2018
Phase: Phase 2
Study type: Interventional

The trial is designed as a randomised, controlled, open, parallel group, multi-centre phase II trial to evaluate clinical efficacy of selinexor in combination with cyclophosphamide and prednisone.

NCT ID: NCT06212284 Completed - Healthy Clinical Trials

Serotonin, Anxiety and Visceral Sensation

Start date: February 18, 2018
Phase: N/A
Study type: Interventional

The goal of this crossover study was to learn about the potential regulatory role of serotonin in interoceptive processing and its relationship to levels of state anxiety. This experiment directly compared the impact of a selective serotonin reuptake inhibitor (SSRI) (20mg CITALOPRAM) to that of a PLACEBO on the neural processing of ordinary interoceptive sensations and the relationship of these influences to anxious states. Healthy young volunteers completed the visceral interoceptive attention task with each treatment condition (citalopram and placebo). The task involves focusing attention on heart, stomach, or visual sensation control while scanned with functional magnetic resonance imaging (fMRI). The difference in haemodynamic response between interoceptive sensation(s) and visual sensation (i.e. the relative interoceptive response) is compared between treatment conditions. State anxiety is measured at each test period. It is used to test for a moderating effect of state anxiety on the influence of serotonin in interoceptive processing and used post-hoc to explore associations between changes in state anxiety and changes of interoceptive relative interoceptive response due to the SSRI.